| Date | Time | Source | Headline | Symbol | Company |
| 05/21/2024 | 4:11PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RXST | RxSight Inc |
| 05/20/2024 | 4:56PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RXST | RxSight Inc |
| 05/16/2024 | 4:30PM | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NASDAQ:RXST | RxSight Inc |
| 05/13/2024 | 4:05PM | GlobeNewswire Inc. | RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares | NASDAQ:RXST | RxSight Inc |
| 05/09/2024 | 4:59PM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:RXST | RxSight Inc |
| 05/09/2024 | 4:41PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RXST | RxSight Inc |
| 05/08/2024 | 9:15PM | GlobeNewswire Inc. | RxSight, Inc. Announces Pricing of Public Offering of Common Stock | NASDAQ:RXST | RxSight Inc |
| 05/08/2024 | 4:41PM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:RXST | RxSight Inc |
| 05/08/2024 | 4:05PM | GlobeNewswire Inc. | RxSight, Inc. Announces Proposed Public Offering of Common Stock | NASDAQ:RXST | RxSight Inc |
| 05/08/2024 | 4:01PM | Edgar (US Regulatory) | Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers | NASDAQ:RXST | RxSight Inc |
| 05/06/2024 | 5:02PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RXST | RxSight Inc |
| 05/06/2024 | 4:15PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:RXST | RxSight Inc |
| 05/06/2024 | 4:10PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RXST | RxSight Inc |
| 05/06/2024 | 4:05PM | GlobeNewswire Inc. | RxSight, Inc. Reports First Quarter 2024 Financial Results | NASDAQ:RXST | RxSight Inc |
| 05/01/2024 | 4:05PM | GlobeNewswire Inc. | RxSight, Inc. to Present at the Bank of America Healthcare Conference | NASDAQ:RXST | RxSight Inc |
| 04/22/2024 | 4:05PM | GlobeNewswire Inc. | RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 | NASDAQ:RXST | RxSight Inc |
| 04/04/2024 | 4:05PM | GlobeNewswire Inc. | RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting | NASDAQ:RXST | RxSight Inc |
| 03/27/2024 | 4:05PM | GlobeNewswire Inc. | RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference | NASDAQ:RXST | RxSight Inc |
| 03/06/2024 | 4:26PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RXST | RxSight Inc |
| 03/06/2024 | 4:25PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RXST | RxSight Inc |
| 03/06/2024 | 4:25PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RXST | RxSight Inc |
| 03/06/2024 | 4:24PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RXST | RxSight Inc |
| 03/05/2024 | 4:05PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RXST | RxSight Inc |
| 03/01/2024 | 4:25PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:RXST | RxSight Inc |
| 02/29/2024 | 7:05PM | GlobeNewswire Inc. | RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference | NASDAQ:RXST | RxSight Inc |
| 02/28/2024 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RXST | RxSight Inc |
| 02/28/2024 | 4:05PM | GlobeNewswire Inc. | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | NASDAQ:RXST | RxSight Inc |
| 02/16/2024 | 5:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RXST | RxSight Inc |
| 02/16/2024 | 4:16PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:RXST | RxSight Inc |
| 02/15/2024 | 4:38PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:RXST | RxSight Inc |